Sabra Health Care

Sabra Health Care REIT, Inc. engages in managing and investing in healthcare-related real estate properties. It focuses on the acquisition, financing and owning real estate property to be leased to third party tenants in the healthcare sector. The company was founded on May 10, 2010 and is headquartered in Irvine, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Sabra Health Care reports strong Q4 performance amidst Enlivant JV challenges

Sabra Health Care showcased improved performance in occupancy rates and revenue growth, with a strategic focus on senior housing opportunities.
Despite challenges from the Enlivant JV impact and market uncertainties, Sabra's strengths in debt management and asset operations position it well for future growth.
Opportunities lie in securing interest rates, expanding in the senior housing sector, and resolving uncertainties around the Enlivant JV for strategic advancement.
Addressing challenges such as transaction market dynamics and maintaining growth momentum will be crucial for Sabra's continued success in the healthcare real estate sector.

Sabra Health Care reports stable Q1 performance amidst market challenges

Sabra Health Care's Q1 2023 performance reflects stability and operational improvements in skilled nursing and senior housing portfolios.
While facing challenges in investment activity and rising debt financing rates, the company is leveraging opportunities in Medicaid rate increases and strategic investments.
Maintaining financial strength and flexibility, Sabra Health Care is poised to navigate market uncertainties and drive operational efficiency.

Sabra Health Care reports robust Q2 performance and eyes 2024 growth

Sabra Health Care's Q2 2023 earnings call highlighted positive performance metrics, ongoing margin recovery efforts, and strategic initiatives to drive occupancy and revenue growth. Despite challenges in the IL segment and market dynamics, the company's strong financial position and focus on portfolio optimization position it well for future opportunities.

Sabra Health Care posts robust Q3 results, eyes growth opportunities

Sabra Health Care's Q3 2023 earnings call reflects strong performance, portfolio stability, and growth potential. Challenges include maintaining coverage ratios and addressing analyst concerns. Opportunities exist in acquisitions, financing, and leveraging portfolio momentum.

Sabra Health Care reports strong Q4 performance and eyes industry growth opportunities

Sabra Health Care showcased strong performance in occupancy and financial metrics, with a focus on operational improvements and growth strategies.
While facing challenges related to occupancy levels and construction costs, the company remains optimistic about industry recovery and growth potential.
Opportunities in the skilled nursing space and sale-leaseback investments present avenues for expansion and strategic development.
Analysts' inquiries and discussions on acquisitions, regulatory issues, and financial guidance reflect a dynamic landscape with potential for strategic advancements.

Sabra Health Care reports solid Q3 performance amidst cautious outlook

Sabra Health Care's Q3 2024 earnings call reflected strong financial performance, strategic focus on quality investments, and cautious outlook on guidance and debt metrics. The company faces competition in skilled nursing but sees opportunities in acquisitions and margin improvement.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Sabra Health Care REIT, Inc. engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.

IRVINE, Calif.--(BUSINESS WIRE)-- #NAREIT--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer, Michael Costa, the company's Chief Financial Officer, Darrin Smith, the company's Executive Vice President of Investments, Jessica Flores, the company's Senior Vice President of Finance and Controller, and Lukas Hartwich, the company's Senior Vice President of Finance, will attend Nareit's REITworld 2023 Annual Conference November 14-15,.

Sabra Health Care REIT, Inc. to Attend Nareit's REITworld 2023 Annual Conference

Apartment Income REIT Corp

Alexandria Real Estate Equities

COPT Defense Properties

Camden Property

First Industrial Realty Trust

Gaming and Leisure Properties

Host Hotels & Resorts

Johnson Controls

Keurig Dr Pepper Inc

LTC Properties

Banco Santander

Telia Co AB

V.F.

Vici Properties

Telefonica Brasil

September-October, 2023, Barron's, Bloomberg, and Fortune analysts and reporters combined to list five sets of stocks sorted as: “Recovery Bets.” Those five articles revealed 53 equities, with 42 paying dividends. These new lists focus on financial services, healthcare, and real estate sectors by Barron's along with selected “change the world” stocks from Fortune and ten to watch from Bloomberg.

18 Buyable Pre-Crash Recovery Equities For October

IRVINE, Calif.--(BUSINESS WIRE)-- #Q32023--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that it will issue its 2023 third quarter earnings release on November 6, 2023, after the close of trading. A conference call with a simultaneous webcast to discuss the 2023 third quarter results will be held on Tuesday, November 7 at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID.

Sabra Health Care REIT, Inc. Announces Third Quarter 2023 Earnings Release Date and Conference Call

Omega Healthcare Investors

Yes, it may sound preposterous, but take a look at some equities you probably aren't familiar with: Omega Healthcare Investors NYSE: OHI, Sabra Health Care REIT NASDAQ: SBRA, and LTC Properties NYSE: LTC.

Nursing Home REITs: The Surprise Heroes of High Yield Investing

Sabra Health Care REIT has defied our expectations and stabilized its funds from operations over the last 9 months. The company has seen occupancy gains in senior housing-leased and behavioral health categories, leading to increased tenant EBITDARM coverage. We give you our outlook for this 9% yielder.

Sabra Health Care: A 9% Yielding Healthcare REIT

IRVINE, Calif.--(BUSINESS WIRE)--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Darrin Smith, the company's Executive Vice President of Investments, Kara Pappanduros, the company's Vice President of Asset Management, and Deb Friedman, the company's Vice President of Asset Management, will attend the AHCA / NCAL Convention and Expo at the Colorado Convention Center in Denver, Colorado from October 1 – 4, 2023. Darrin Smith will participate in the REITs Offer Options and Updates.

Sabra Health Care REIT, Inc. to Participate in the AHCA / NCAL Convention and Expo and the INVEST Conference

IRVINE, Calif.--(BUSINESS WIRE)-- #BofAConference--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer, Talya Nevo-Hacohen, the company's Chief Investment Officer, and Eliza Gozar, the company's Senior Vice President of Investments, will participate in the eCap West Healthcare Conference September 5 - 7, 2023 at the Arizona Biltmore in Phoenix, Arizona. Additionally, on September 12 – 13, 2023, Rick Matros, Talya Nevo-Hacohen, Michael Cost.

Sabra Health Care REIT, Inc. to Participate in the eCap West Healthcare Conference and BofA Securities 2023 Global Real Estate Conference

BrightSpire Capital

Blackstone Mortgage Trust

Easterly Government Properties

Global Net Lease

REITs are cheap and undervalued. But some REIT dividends are risky. I highlight 5 REITs that I think are likely to cut their dividends.

5 REITs That Will Likely Cut Their Dividends

Sabra Health Care REIT, Inc. (NASDAQ:SBRA ) Q2 2023 Earnings Conference Call August 8, 2023 1:00 PM ET Company Participants Lukas Hartwich - Senior Vice President, Finance Rick Matros - Chief Executive Officer, President and Chair of the Board Talya Nevo-Hacohen - Chief Investment Officer, Treasurer and Executive Vice President Michael Costa - Chief Financial Officer, Secretary and Executive Vice President Conference Call Participants Juan Sanabria - BMO Capital Markets Austin Wurschmidt - KeyBanc Capital Markets Vikram Malhotra - Mizuho Tao Qiu - Berenberg Michael Griffin - Citi Joshua Dennerlein - Bank of America Steven Valiquette - Barclays John Pawlowski - Green Street Advisors Operator Good day, everyone. My name is Mandeep, and I'll be your conference operator today.

Sabra Health Care REIT, Inc. (SBRA) Q2 2023 Earnings Call Transcript

Although the revenue and EPS for Sabra (SBRA) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Sabra (SBRA) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Sabra Healthcare (SBRA) came out with quarterly funds from operations (FFO) of $0.34 per share, in line with the Zacks Consensus Estimate. This compares to FFO of $0.39 per share a year ago.

Sabra Healthcare (SBRA) Q2 FFO Meet Estimates

IRVINE, Calif.--(BUSINESS WIRE)-- #2Q23--Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the second quarter of 2023. SECOND QUARTER 2023 RESULTS AND RECENT EVENTS Results per diluted common share for the second quarter of 2023 were as follows: Net Income: $0.09 FFO: $0.32 Normalized FFO: $0.33 AFFO: $0.33 Normalized AFFO: $0.34 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 1.65x (1.57x excluding Provider Relief F.

Sabra Reports Second Quarter 2023 Results

IRVINE, Calif.--(BUSINESS WIRE)-- #2Q23--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that it will issue its 2023 second quarter earnings release on August 7, 2023, after the close of trading. A conference call with a simultaneous webcast to discuss the 2023 second quarter results will be held on Tuesday, August 8 at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID n.

Sabra Health Care REIT, Inc. Announces Second Quarter 2023 Earnings Release Date and Conference Call

IRVINE, Calif.--(BUSINESS WIRE)-- #Sustainability--Sabra Health Care REIT, Inc. (“Sabra,” or “we”) (Nasdaq: SBRA) today released its third annual Sustainability Report. The report showcases our programs, policies and initiatives that support our environmental, social and governance (ESG) priorities of environmental stewardship; diversity, equity and inclusion; human capital management; protection of health, wellness and safety of our stakeholders; engagement and collaboration with our operators and tenants; cybe.

Sabra Publishes Third Annual Sustainability Report

Rose's Income Garden Portfolio owns Sabra Health Care, a healthcare facility real estate investment trust, which offers a 9.6% dividend yield. Sabra owns or runs 396 real estate properties across the US and Canada, including skilled nursing/transitional care facilities, senior housing communities, and specialty hospitals. Analysts suggest Sabra's stock is undervalued and predict earnings growth into 2024, with the potential for a dividend increase in 2025.

Sabra Health Care REIT: 9.6% Yield, Price And Prognosis Improving

Digital Realty Trust

Veris Residential

Much like the rest of the real estate market, real estate investment trusts (REITs) have their ups and downs. They are a popular way to get into the business without having to deal directly with property.

3 REITs To Sell Before They Do Your Portfolio In

Agree Realty

City Office REIT

CTO Realty Growth

CareTrust REIT

Elme Communities

Four Corners Property Trust

Global Medical REIT

Getty Realty

National Retail Properties

NETSTREIT Corp

Corporate Office Properties Trust

Retail Opportunity Investments

Ramco-Gershenson Properties

Spirit Realty Capital

Investors have good reason to be concerned about the real-estate market. It has been obvious for decades that the U.S. has too many retail properties, and now, changing work habits promise to put downward pressure on office lease prices for years to come.

Do you need investment income? Here are 20 REIT stocks with dividends expected to be well supported through 2025.

Sabra Health Care REIT operates nursing facilities and senior housing facilities. The REIT has low occupancy and was hit hard during Covid resulting in a low FFO multiple. I present my analysis that leads me to a Hold rating.

Sabra Health Care: Risks Outweigh The Benefits

Hudson Pacific Properties

Paramount Group

SL Green Realty

Rising interest rates and the economic slowdown have already weighed on real estate investment trusts (REITs). Unfortunately, there are still plenty of REITs to sell before they drop even further.

7 REITs to Sell Before They Crumble Under Pressure

Sabra is a skilled nursing and senior housing provider which has struggled with occupancy since the pandemic started. Occupancy is improving slowly, but tenant coverage remains extremely tight significantly increasing risks for SBRA.

Sabra Health Care: The Reward Doesn't Justify The Risks

IRVINE, Calif.--(BUSINESS WIRE)-- #NAREIT--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer, Michael Costa, the company's Chief Financial Officer, Talya Nevo-Hacohen, the company's Chief Investment Officer, and Lukas Hartwich, the company's Senior Vice President of Finance, will participate in Nareit's REITweek 2023 Investor Conference June 6 - 8, 2023 at the New York Hilton Midtown. About Sabra Sabra Health Care REIT, Inc., a M.

Sabra Health Care REIT, Inc. to Participate in Nareit's REITweek 2023 Investor Conference

Sabra Health Care REIT, Inc. (NASDAQ:SBRA ) Q1 2023 Earnings Conference Call May 4, 2023 1:00 PM ET Company Participants Lukas Hartwich - Senior Vice President, Finance Rick Matros - Chief Executive Officer, President and Chair Talya Nevo-Hacohen - Chief Investment Officer, Treasurer and Executive Vice President Michael Costa - Chief Financial Officer, Secretary and Executive Vice President Conference Call Participants Michael Griffin - Citi Omotayo Okusanya - Credit Suisse Joshua Dennerlein - Bank of America Austin Wurschmidt - KeyBanc Capital Markets Steven Valiquette - Barclays Vikram Malhotra - Mizuho Michael Stroyeck - Green Street Juan Sanabria - BMO Capital Markets Operator Good day, everyone. My name is Lisa and I will be your conference operator today.

Sabra Health Care REIT, Inc. (SBRA) Q1 2023 Earnings Call Transcript

The headline numbers for Sabra (SBRA) give insight into how the company performed in the quarter ended March 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Sabra (SBRA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Sabra Healthcare (SBRA) Matches Q1 FFO Estimates

IRVINE, Calif.--(BUSINESS WIRE)-- #1Q23--Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the first quarter of 2023. FIRST QUARTER 2023 RESULTS AND RECENT EVENTS Results per diluted common share for the first quarter of 2023 were as follows: Net Loss: $(0.04) FFO: $0.32 Normalized FFO: $0.33 AFFO: $0.33 Normalized AFFO: $0.34 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 1.63x 1.55x (excluding Provider Relief Fund.

Sabra Reports First Quarter 2023 Results

News for Sabra Health Care Stock (SBRA)